CRPCG is part of the China Resources Pharmaceutical Group, which is the second largest pharmaceutical manufacturer and one of the three largest pharmaceutical distributors by revenue in China.
Specialty pharmaceutical company iX Biopharma has entered into a strategic cooperation framework agreement with China Resources Pharmaceutical Commercial Group Co (CRPCG) to collaborate on the sale and distribution of iX Biopharma products in China.
Under the agreement, the parties will determine the products and model of cooperation, which may be via licensing or joint venture. CRPCG will undertake the full scope of operations in China including registration, manufacturing, distribution, and promotion.
